Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Inflammatory cortical demyelination in early multiple sclerosis.
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.
Interferon Beta-1b may reverse axonal dysfunction in multiple sclerosis.
Regenerative cellular therapies for neurologic diseases.
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Glatiramer acetate in the treatment of multiple sclerosis
Intas launches biosimilar version of Rituximab
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Pharmacology and therapeutic potential of interferons.
Inflammation-induced fatigue: Exploring neurobiological mechanisms and potential treatments
Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Cognitive impairment in multiple sclerosis.
Multiple sclerosis: risk factors, prodromes, and potential causal pathways.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.

Pages